TipRanks
Advertisement
Advertisement

CPRX Stock Latest News

Is CPRX a Buy, Before Earnings?
Pre-EarningsIs CPRX a Buy, Before Earnings?
2M ago
CPRX
Solaris to replace Catalyst Pharmaceuticals in the S&P 600 at open on 7/15
PremiumThe Fly
Solaris to replace Catalyst Pharmaceuticals in the S&P 600 at open on 7/15
3M ago
SEI
CPRX
Catalyst Pharma Shareholders Approve Angelini Merger Agreement
PremiumCompany Announcements
Catalyst Pharma Shareholders Approve Angelini Merger Agreement
3M ago
8K
CPRX
Catalyst Pharma reports positive Phase 1 AGAMREE results
PremiumCompany Announcements
Catalyst Pharma reports positive Phase 1 AGAMREE results
3M ago
8K
CPRX
Catalyst Pharma Gains FTC Clearance for Angelini Merger
PremiumCompany Announcements
Catalyst Pharma Gains FTC Clearance for Angelini Merger
4M ago
8K
CPRX
Catalyst Pharmaceuticals Sets July 2026 Vote on $31.50-per-Share Angelini Pharma Buyout
PremiumCompany AnnouncementsCatalyst Pharmaceuticals Sets July 2026 Vote on $31.50-per-Share Angelini Pharma Buyout
4M ago
CPRX
Catalyst Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Catalyst Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
4M ago
CPRX
Catalyst Pharmaceuticals reports Q1 non-GAAP EPS 79c, consensus 64c
Premium
The Fly
Catalyst Pharmaceuticals reports Q1 non-GAAP EPS 79c, consensus 64c
5M ago
CPRX
Catalyst Pharmaceuticals not providing forward-looking guidance
PremiumThe Fly
Catalyst Pharmaceuticals not providing forward-looking guidance
5M ago
CPRX
Catalyst Pharma Reports Higher Revenue, Suspends Earnings Guidance
PremiumCompany Announcements
Catalyst Pharma Reports Higher Revenue, Suspends Earnings Guidance
5M ago
8K
CPRX
CPRX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CPRX Upcoming Earnings Report: What to Expect?
5M ago
CPRX
Catalyst Pharmaceuticals downgraded to Neutral from Buy at Citi
PremiumThe Fly
Catalyst Pharmaceuticals downgraded to Neutral from Buy at Citi
5M ago
CPRX
Catalyst Pharmaceuticals downgraded to Neutral from Outperform at Baird
PremiumThe FlyCatalyst Pharmaceuticals downgraded to Neutral from Outperform at Baird
5M ago
CPRX
Catalyst Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
Premium
The Fly
Catalyst Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
5M ago
CPRX
Catalyst Pharma Settles Firdapse Patent Litigation With Hetero
Premium
Company Announcements
Catalyst Pharma Settles Firdapse Patent Litigation With Hetero
5M ago
8K
CPRX
Catalyst Pharmaceuticals downgraded to Equal Weight from Overweight at Stephens
PremiumThe Fly
Catalyst Pharmaceuticals downgraded to Equal Weight from Overweight at Stephens
5M ago
CPRX
Catalyst Pharmaceuticals to be acquired by Angelini Pharma for $31.50 per share
PremiumThe Fly
Catalyst Pharmaceuticals to be acquired by Angelini Pharma for $31.50 per share
5M ago
BX
CPRX
Analyst Initiates Buy on Catalyst Pharma, Citing M&A Appeal, Rare Disease Growth and $35 Price Target Backed by Strong Balance Sheet
PremiumRatings
Analyst Initiates Buy on Catalyst Pharma, Citing M&A Appeal, Rare Disease Growth and $35 Price Target Backed by Strong Balance Sheet
5M ago
CPRX
Angelini exploring acquisition of Catalyst Pharmaceuticals, Bloomberg says
PremiumThe Fly
Angelini exploring acquisition of Catalyst Pharmaceuticals, Bloomberg says
5M ago
CPRX
Catalyst Pharmaceuticals trading resumes
PremiumThe FlyCatalyst Pharmaceuticals trading resumes
5M ago
CPRX
Catalyst Pharmaceuticals trading halted, volatility trading pause
Premium
The Fly
Catalyst Pharmaceuticals trading halted, volatility trading pause
5M ago
CPRX
Catalyst Pharma Patent Trial Against Hetero USA Delayed
Premium
Company Announcements
Catalyst Pharma Patent Trial Against Hetero USA Delayed
7M ago
8K
CPRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >